The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multi-institutional prospective cohort study of minimal residual disease in peripheral T-cell lymphoma: Impact of autologous stem cell transplant.
 
Nicole C. Foley
No Relationships to Disclose
 
David Russler-Germain
No Relationships to Disclose
 
Marcus Watkins
No Relationships to Disclose
 
Eric D. Jacobsen
Consulting or Advisory Role - Janssen; Merck; Seagen
Research Funding - Celgene
Travel, Accommodations, Expenses - Merck
 
Alison J. Moskowitz
Honoraria - Seagen
Consulting or Advisory Role - ADC Therapeutics; Bristol-Myers Squibb; Imbrium Therapeutics; Janpix; Kyowa Kirin International; Merck; miRagen; Seagen; Takeda
Research Funding - ADC Therapeutics (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); miRagen (Inst); Seagen (Inst)
 
Amanda F. Cashen
Research Funding - Secura Bio
 
Todd A. Fehniger
Stock and Other Ownership Interests - Indapta Therapeutics; Kiadis Pharma; Orca Bio
Honoraria - CytoSen
Consulting or Advisory Role - Nektar; Nkarta
Research Funding - Affimed Therapeutics (Inst); Altor BioScience (Inst); Compass Therapeutics (Inst)
Travel, Accommodations, Expenses - Miltenyi Biotec
 
Brad S. Kahl
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; BeiGene; Bristol-Myers Squibb; Genentech; Incyte; Janssen; Kite/Gilead; MEI Pharma; Roche; Seattle Genetics/Astellas; TG Therapeutics
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Genentech (Inst)
 
Armin Ghobadi
Honoraria - Kite, a Gilead Company
Consulting or Advisory Role - Amgen; Celgene; Kite, a Gilead Company; WUGEN, Inc.
Speakers' Bureau - Kite, a Gilead Company
Research Funding - Amgen; Kite, a Gilead Company
 
Beth Reagan
No Relationships to Disclose
 
Anne Fischer
No Relationships to Disclose
 
Fei Wan
No Relationships to Disclose
 
Austin Jacobsen
Employment - Invivoscribe
 
Karina Elias
Employment - Invivoscribe
 
Matt Holman
Employment - Invivoscribe
 
Natalie Hill
Employment - Invivoscribe
 
Skyler Gordon
Employment - Invivoscribe
 
Ying Huang
Employment - Invivoscribe
 
Steven M. Horwitz
Consulting or Advisory Role - Acrotech Biopharma; ADC Therapeutics; Astex Pharmaceuticals; C4 Therapeutics; Celgene; Janssen Oncology; Kura Oncology; Kyowa Hakko Kirin; Millennium; Myeloid Therapeutics; Ono Pharmaceutical; Seagen; Secura Bio; Shoreline Biosciences; Takeda; Trillium Therapeutics; Tubulis GmbH; Verastem; Vividion Therapeutics
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); Aileron Therapeutics (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Forty Seven (Inst); Kyowa Hakko Kirin (Inst); Seagen (Inst); Secura Bio (Inst); Takeda (Inst); Trillium Therapeutics (Inst); Verastem (Inst)
 
Neha Mehta-Shah
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/UCB Japan; Genentech/Roche; Kyowa Hakko Kirin; Secura Bio
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); C4 Therapeutics (Inst); Celgene (Inst); Corvus Pharmaceuticals (Inst); Daiichi Sankyo; Dizal Pharma (Inst); Genentech/Roche (Inst); Innate Pharma (Inst); Verastem (Inst); Yingli Pharma (Inst)